Teligent
TLGT
#10576
Rank
โ‚ฌ14.17 M
Marketcap
0,15ย โ‚ฌ
Share price
-13.85%
Change (1 day)
1,648.29%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Revenue for Teligent (TLGT)

Revenue in 2021 (TTM): โ‚ฌ38.98 Million

According to Teligent's latest financial reports the company's current revenue is โ‚ฌ40.75 Million. In 2020 the company made a revenue of โ‚ฌ39.88 Million a decrease over the revenue in the year 2019 that were of โ‚ฌ58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Teligent from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ38.98 M-2.24%
2020โ‚ฌ39.88 M-31.24%
2019โ‚ฌ58 M-0.71%
2018โ‚ฌ58.41 M-1.31%
2017โ‚ฌ59.19 M0.55%
2016โ‚ฌ58.86 M51.14%
2015โ‚ฌ38.94 M31.15%
2014โ‚ฌ29.69 M85.15%
2013โ‚ฌ16.03 M112.81%
2012โ‚ฌ7.53 M9.7%
2011โ‚ฌ6.87 M28.07%
2010โ‚ฌ5.36 M61.33%
2009โ‚ฌ3.32 M-7.15%
2008โ‚ฌ3.58 M-11.18%
2007โ‚ฌ4.03 M74.85%
2006โ‚ฌ2.3 M-8.62%
2005โ‚ฌ2.52 M-8.84%
2004โ‚ฌ2.76 M-11.58%
2003โ‚ฌ3.13 M-51.95%
2002โ‚ฌ6.51 M-54.52%
2001โ‚ฌ14.32 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚ฌ0.56 B 1,286.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ0.19 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA